According to Viracta Therapeutics's latest financial reports the company's current earnings (TTM) are -C$61.5 M. In 2023 the company made an earning of -C$69.26 M a decrease over its 2022 earnings that were of -C$66.74 M.The earnings displayed on this page is the company's Pretax Income.